Back to search

Article

TROP2 expression is associated with early stage and favorable prognosis in Upper tract urothelial carcinoma

2025-11-06

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> TROP2 has recently emerged as a promising therapeutic target, with the antibody‒drug conjugate sacituzumab govitecan. Nevertheless, its biological and clinical relevance in urothelial carcinoma (UC) has not been fully investigated. <bold>Methods</bold> : We evaluated TROP2 protein expression in 114 upper tract UC (UTUC) tissue samples using immunohistochemi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05a15c9b-de99-58a9-9694-c028d36c3b94
DOI
10.21203/rs.3.rs-7734563/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TROP2 expression is associated with early stage and favorable prognosis in Upper tract urothelial carcinomaDOI 10.21203/rs.3.rs-7734563/v1
Select a neighboring publication to make it the new centre.